Decreasing the time from gut microbiota analysis to publication
An increasing number of researchers have discovered the efficiency and simplicity of performing gut microbiota analysis using the GA-map® Dysbiosis Test.
The technology uses single nucleotide differences in the 16S rRNA gene to measure the abundance of species and groups of bacteria in a fecal sample. All pre-processing of the data is done by the GA-map® Analyzer software, hence no bioinformatician resources needed. Reports for microbiota profiles are automatically generated containing information on the dysbiosis index a measure of bacteria profile changes calculated based on the deviation from a reference population.
Merging the rapidness, preciseness and robustness of RT-PCR approach with the comprehensiveness of next-generation sequencing, the GA-map® technology drastically reduces the time from analysis to publication. Below, a selection of publications performed by using the GA-map® Dysbiosis Test is presented.
Number of publications: 21
FOR THE FULL LIST, please see our resource library section where it can be downloaded.
Books and book chapters
1. Casén C. Textbook “Microbiology: an Evolving Science”. Chapter 28 opening research highlight and interview; ‘Clinical Microbiology and Epidemiology’, 2016;
Prof John W. Foster, Dept of Microbiology and Immunology College of Medicine, University of South Alabama
Posters and Presentations
25. Accepted abstract (oral) PIBD Sept 2017; Dr Christine Olbjørn, NO; Faecal microbiota dysbiosis in paediatric inflammatory bowel disease persists after therapy
24. Poster DDW May 2017; Dr Christine Olbjørn, NO; Microbial characterization of pediatric inflammatory bowel disease and stratification into disease severity groups
23. Oral presentation DDW May 2017; Dr Jørgen Valeur, NO; Microbial DNA markers associated with response to a low FODMAP diet in patients with irritable bowel syndrome
22. Poster ECCO Feb 2017; Dr Petr Ricanek, NO; Microbiota related disease activity and distribution in subgroups of IBD
21. Poster ECCO Feb 2017; Dr Christine Olbjørn, NO Microbial characterization of paediatric inflammatory bowel disease and stratification into disease severity groups
20. Oral presentation UEGW Oct 2016; Sean Bennet, SE (Awarded one of top 5 abstracts) Multivariate modelling of gut microbial profiles predicts responsiveness to a diet low in FODMAPs
19. Poster UEGW Oct 2016; German multicenter study, Prof Wolfgang Kruis, Köln, GE; Performance Evaluation of Dysbiosis Status as A Tool For Clinical Investigation In Patients With Functional Gastrointestinal Disorders
18. Oral Presentation UEGW Oct 2016; Dr Petr Ricanek, NO; Microbiota Alterations In Treatment Naïve IBD and Non-IBD Patients – The EU IBD-Character Project
17. Oral Presentation UEGW Oct 2016; Rebiotix, Courtney Jones, USA; Rebiotix – Consistent and Reproducible Production of a Microbiota-based Drug for Recurrent C . difficile Infection: Application of a Novel Diagnostic for Dysbiosis
16. Poster UEGW Oct 2016; Dr Jostein Sauar, NO; Dysbiosis and stability over 2 years in patients with irritable bowel syndrome
15. Poster UEGW Amsterdam Oct 2012; Caroline Frøyland, NO; Development of a new, rapid gut microbiota test for analysis of IBD (GA)
14. Poster UEGW Oct 2016; Tonje Hustoft, NO; IBS patients on 3 weeks Low FODMAP Diet followed by 3 weeks High FODMAP Diet
13. Oral Presentation UEGW Oct 2016; Dr Tarek Mazzawi, NO; IBS and Fecal Microbiota Transplant (FMT)
12. Presentation ECCO Amsterdam March 2016, Christina Casen, NO; A novel diagnostic test for determining microbial dysbiosis
11. Oral present ECCO Amsterdam March 2016, Petr Ricanek, NO; Microbiota profiles in treatment naïve Norwegian IBD and non IBD patients.
10. Poster ICMI Seattle 2015; Prof Lena Öhman, Gothenburg, SE; The importance of the mucosal antimicrobial peptide expression and gut microbiota in anti-TNF therapy response in ulcerative colitis
9. Poster Targeting Microbiota, Paris Oct 2015; Caroline J Frøyland (GA); Stability of repeated fecal DNA preparation using the GA-map™ Dysbiosis Test
8. Poster UEGW Vienna Oct 2014; Dr Jorgen Valeur, Oslo, NO; Influence of a low-FODMAP diet on symptoms and gut microbiota in patients with irritable bowel syndrome
7. Poster UEGW Vienna 2014; Dr Kristoffer Kofod Vinding, DK; Gut Microbiota alterations in IBS patients before and after 6 weeks of low FODMAP diet versus Lactobacillus Rhamnosus GG
6. Poster DDW Chicago 2014; Dr Natalia Pedersen, DK; Gut microbiota in IBD patients with IBS before and after 6 weeks of low FODMAP diet
5. Poster ECCO Copenhagen Feb 2014; Dr Finn T. Hegge, NO; Microbiota stability in vivo and in vitro (GA)
4. Poster ECCO Copenhagen Feb 2014; Dr Natalia Pedersen, DK; Gut microbiota alterations in IBD patients with IBS symptoms before and after 6 weeks of low FODMAP diet
3. Poster UEGW Berlin Oct 2013; Dr Heidi Vebø, NO; Microbiota analysis in IBS and IBD/non-IBD patients and normal subjects (GA)
2. Poster DDW Orlando May 2013; Dr Heidi Vebø, NO; New test for profiling of the gut microbiota in IBS, non-IBD and IBD patients (GA)
1. Poster ECCO Vienna Feb 2013; Dr Heidi Vebø, NO; New test for profiling of the gut microbiota in non-IBD and IBD patients (GA)